Metastatic cervical cancer: clinical experience with pembrolizumab application. Case report
Cervical cancer (CC) ranks fourth for cancer incidences in women after breast cancer, colorectal cancer and lung cancer. There is a steady increase in the incidence of invasive forms of CC in Russia. Over the past quarter of a century, the mortality rate of reproductive age group women with cervical...
Saved in:
| Main Authors: | Anna E. Protasova, Liubov V. Strakh, Elena I. Lando, Elena V. Sidorkina |
|---|---|
| Format: | article |
| Language: | RU |
| Published: |
IP Habib O.N.
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/1bee8f325e5a4877b199e5b990bdcf02 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel therapeutic strategies for patients with metastatic triple-negative breast cancer
by: Inna P. Ganshina, et al.
Published: (2021) -
Abemaciclib in Combination With Pembrolizumab for Stage IV KRAS-Mutant or Squamous NSCLC: A Phase 1b Study
by: Jean-Louis Pujol, MD, PhD, et al.
Published: (2021) -
Combination Therapy of Pembrolizumab plus Axitinib for a Patient on Hemodialysis with Metastatic Renal Cell Carcinoma: A Case Report
by: Yuki Katsumata, et al.
Published: (2021) -
Cautious addition of targeted therapy to PD-1 inhibitors after initial progression of BRAF mutant metastatic melanoma on checkpoint inhibitor therapy
by: Wolfram Samlowski, et al.
Published: (2021) -
Robust response of pulmonary pleomorphic carcinoma to pembrolizumab and sequential radiotherapy: A case report
by: Tae‐Hun Kim, et al.
Published: (2021)